000 01260 a2200325 4500
005 20250515125248.0
264 0 _c20081023
008 200810s 0 0 eng d
022 _a0264-410X
024 7 _a10.1016/j.vaccine.2008.06.058
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWright, A K A
245 0 0 _aProspects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection.
_h[electronic resource]
260 _bVaccine
_cSep 2008
300 _a4893-903 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aAdjuvants, Immunologic
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aHumans
650 0 4 _aImmunity, Mucosal
650 0 4 _aInterleukin-12
_xadministration & dosage
650 0 4 _aPneumococcal Infections
_ximmunology
650 0 4 _aPneumococcal Vaccines
_xadministration & dosage
650 0 4 _aRespiratory Tract Infections
_ximmunology
700 1 _aBriles, D E
700 1 _aMetzger, D W
700 1 _aGordon, S B
773 0 _tVaccine
_gvol. 26
_gno. 38
_gp. 4893-903
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2008.06.058
_zAvailable from publisher's website
999 _c18084773
_d18084773